| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | -87.4% |
| Cost of Revenue | $2.7M | -83.6% |
| Gross Profit | $467K | -94.7% |
| R&D Expense | $417K | -69.3% |
| SG&A Expense | $6.1M | -60.1% |
| Operating Income | -$7.7M | +53.8% |
| Interest Expense | $21K | -97.8% |
| Pre-tax Income | -$7.7M | +53.1% |
| Income Tax | $0 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $406K | -87.3% |
| Current Assets | $2.0M | -53.4% |
| Total Assets | $10.5M | -25.8% |
| Current Liabilities | $9.6M | +22.6% |
| Total Liabilities | $9.6M | +5.5% |
| Stockholders' Equity | $930K | -81.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$947K | +86.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $1.0M | -82.2% |
| Free Cash Flow | -$947K | +86.5% |
| — |
| Net Income | -$6.7M | +59.6% |